Dynamic Technology Lab Private Ltd Takes Position in Ardent Health, Inc. $ARDT

Key Points

• Dynamic Technology Lab Private Ltd has made a new investment of approximately $469,000 in Ardent Health, acquiring 34,144 shares in the company during the first quarter.
• Ardent Health reported an earnings per share (EPS) of $0.52, surpassing analysts' estimates of $0.30 for the latest quarter, with revenues of $1.65 billion.
• Several analysts have adjusted their price targets for Ardent Health, with JPMorgan reducing its target from $18.00 to $15.00, while Stephens set a higher target of $21.00.

Dynamic Technology Lab Private Ltd acquired a new stake in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 34,144 shares of the company's stock, valued at approximately $469,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ARDT. Nuveen Asset Management LLC boosted its stake in Ardent Health by 220.6% during the fourth quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company's stock worth $2,895,000 after buying an additional 116,610 shares during the last quarter. Vanguard Group Inc. lifted its stake in Ardent Health by 368.9% during the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock worth $18,296,000 after acquiring an additional 1,046,845 shares in the last quarter. Trexquant Investment LP acquired a new position in Ardent Health during the 1st quarter worth about $1,537,000. Rhumbline Advisers increased its holdings in Ardent Health by 46.8% during the 1st quarter. Rhumbline Advisers now owns 24,827 shares of the company's stock worth $341,000 after purchasing an additional 7,914 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in Ardent Health during the 1st quarter worth about $2,886,000.

Analyst Ratings Changes

A number of research firms have recently commented on ARDT. JPMorgan Chase & Co. dropped their price objective on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. KeyCorp decreased their price objective on Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a research report on Tuesday, May 20th. Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Finally, UBS Group started coverage on Ardent Health in a report on Wednesday, September 10th. They issued a "buy" rating and a $17.00 price target for the company. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Ardent Health has a consensus rating of "Moderate Buy" and a consensus target price of $19.33.

Ardent Health Stock Up 1.3%

Ardent Health stock traded up $0.17 during midday trading on Tuesday, hitting $12.85. 372,435 shares of the company were exchanged, compared to its average volume of 266,205. The company's fifty day moving average price is $12.28 and its 200-day moving average price is $13.10. The company has a market cap of $1.84 billion, a PE ratio of 7.10, a price-to-earnings-growth ratio of 5.61 and a beta of 0.30. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00. Ardent Health, Inc. has a fifty-two week low of $10.10 and a fifty-two week high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%.The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, research analysts predict that Ardent Health, Inc. will post 1.23 EPS for the current fiscal year.

Ardent Health Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.